Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Audited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 We write to inform you that in accordance with the provisions of Regulation 33 of the Listing Regulations, the Board of Directors of the Company at its meeting held on June 29, 2020 has, inter alia, approved the Audited Financial Results of the Company (Standalone and Consolidated) for the quarter and financial year ended March 31, 2020. The Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2020 along with the Auditors' Reports issued by Deloitte Haskins & Sells, LLP, Chartered Accountants, dated June 29, 2020 and the Statement on Impact of Audit Qualifications (for Audit Report with modified opinion) are enclosed herewith.
29-06-2020
Bigul

Annual report for Fermenta Biotech Ltd. for FY-2020
29-06-2020
Bigul

Fermenta Biotech Ltd - 506414 - Board to consider Final Dividend

 Fermenta Biotech Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on June 29, 2020, inter alia:1. To consider and approve the audited financial statements of the Company (standalone and consolidated) for the quarter and financial year ended March 31, 2020; and2. To consider and recommend final equity dividend, if any, for the financial year 2019-20.Pursuant to Company's earlier Notice for the Closure of Trading Window dated March 31, 2020 and in accordance withthe provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders and in terms of BSE Circular dated April 02, 2019, the "Trading Window" (period for trading in Company's securities) has been closed with effect from April 01, 2020 and shall continue to remain closed till 48 hours after declaration of financial results for the quarter and financial year ended March 31, 2020. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's Equity Shares, either in their own name or in the name of their immediate relatives.
19-06-2020
Bigul

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

 Pursuant to Regulation 29 of SEBI LODR, 2015, we hereby inform you that meeting of the Board of Directors of the Company is scheduled to be held on Monday, June 29, 2020. Pursuant to our earlier Notice for the Closure of Trading Window dated March 31, 2020 and in accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company''s Code of Conduct to Regulate, Monitor and Report Trading by Insiders and in terms of BSE Circular LIST/COMP/01/2019-20 dated April 2, 2019, the 'Trading Window" (period for trading in Company's securities) has been closed with effect from April 1, 2020 and shall continue to remain closed till 48 hours after declaration of financial results for the quarter and financial year ended March 31, 2020.
19-06-2020
Bigul

Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Notice Of Board Meeting And Closure Of Trading Window

 Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI LODR, 2015, we hereby inform you that meeting of the Board of Directors of the Company is scheduled to be held on Monday, June 29, 2020, inter alia:(a)to consider and approve the audited financial statements of the Company for the quarter and financial year ended 31.3.2020; and(b)to consider and recommend final equity dividend, if any, for the financial year 2019-20. Pursuant to our earlier Notice for the Closure of Trading Window dated March 31, 2020 and in accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company''s Code of Conduct to Regulate, Monitor and Report Trading by Insiders and in terms of BSE Circular LIST/COMP/01/2019-20 dated April 2, 2019, the 'Trading Window" (period for trading in Company's securities) has been closed with effect from April 1, 2020 and shall continue to remain closed till 48 hours after declaration of financial results for the quarter and financial year ended March 31, 2020.
19-06-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Intimation of Revised Investor Relations Presentation With reference and further to our intimation dated June 8, 2020 filed with BSE Limited regarding 'Intimation of Investor Related Presentation' we wish to inform you that inadvertently there was a typographical error on page number 24 of the Investor Presentation titled as Vitamin D3 500 Animal Feed Price Trend where the Min of Low for 2019 was shown as Euro 37.00 whereas it should read as Euro 12.50. We regret the inconvenience caused and hereby enclose a revised copy of Investor Relations Presentation for June 2020 for your information. The said Investor Presentation is also available on Company's website at www.fermentabiotech.com Kindly take the same on records.
09-06-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Intimation of Investor Relations Presentation Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation for June 2020 for your information. The said Investor Presentation is also available on Company's website at www.fermentabiotech.com Kindly take the same on records.
08-06-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances

 Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Disclosure relating to impact of CoVID-19 pandemic on the Company Intimation dated (i) March 25, 2020 regarding 'Suspension of Company's manufacturing operations at Dahej and Kullu' and (ii) April 4, 2020 regarding 'Resumption of partial production activities at Company's manufacturing facility at Kullu and Dahej' ('Intimations') Pursuant to Regulation 30 of Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020 and further to above referred Intimations, please find enclosed herewith an update relating to the impact of the CoVID-19 pandemic and the resultant lockdown, on the operations of the Company and the current status. This is for your information and record please.
05-06-2020
Bigul

Fermenta Biotech Ltd - 506414 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') Regarding Incorporation Of A Wholly-Owned Subsidiary In USA

 Pursuant to Regulation 30 of Listing Regulations, we would like to inform that in order to facilitate exports and enhance Company's business, the Company has incorporated a wholly-owned subsidiary in the name of 'Fermenta Biotech USA LLC' with effect from May 27, 2020, having its registered office at 919, North Market Street, Suite 950, Wilmington, Delaware, 19801, the United States of America.
01-06-2020
Bigul

Fermenta Biotech Ltd - 506414 - Compliance Certificate Under Regulation 40(9) Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') For Half Year Ended March 31, 2020

 Pursuant to Regulation 40(9) of the Listing Regulations, we are enclosing Certificate dated May 08, 2020 issued by M/s V. N. Deodhar & Co., Company Secretaries, for the half year ended March 31, 2020.
08-05-2020
Next Page
Close

Let's Open Free Demat Account